GlassScriptPhysician profile
Perry Lance Justice
NPI 1902061542
$4,663.34
in general payments reported to CMS, 2019-2025
26 companies · $3,503 in 2025
The $3,503 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $307 · 2020: $109 · 2021: $251 · 2022: $215 · 2023: $154 · 2024: $125 · 2025: $3,503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $453 · Travel and Lodging: $328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $453.30 |
| Travel and Lodging | $328.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,424.67 | 2025 | |
| Abbvie INC. | $187.92 | 2019-2022 | |
| Stryker Corporation | $114.49 | 2019 | |
| Mylan Pharmaceuticals INC. | $108.87 | 2019-2022 | |
| Medtronic, INC. | $96.68 | 2022-2024 | Ligasure |
| Shield Therapeutics INC | $70.35 | 2023-2025 | Accrufer |
| Organon LLC | $69.22 | 2022-2025 | Jada System |
| Aspira Women'S Health INC | $66.53 | 2021 | |
| Hologic Sales and Service, LLC | $64.00 | 2019-2023 | Novasure |
| Bayer Healthcare Pharmaceuticals INC. | $59.26 | 2023 | |
| Therapeuticsmd, INC. | $58.94 | 2019-2022 | |
| Pfizer INC. | $39.13 | 2021-2023 | |
| Astellas Pharma US INC | $34.62 | 2024 | Veozah |
| Sage Therapeutics, LLC | $34.29 | 2024-2025 | Zurzuvae |
| Amgen INC. | $30.07 | 2019-2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $29.34 | 2021 | |
| Conmed Corporation | $24.58 | 2019-2020 | |
| Dexcom, INC. | $23.69 | 2025 | Dexcom G6 Transmitter |
| Minerva Surgical, INC | $19.66 | 2023 | |
| Myovant Sciences INC. | $18.25 | 2022 | |
| Scynexis, INC. | $17.97 | 2021 | |
| Monaghan Medical Corporation | $15.83 | 2023 | Aerobika |
| Alexion Pharmaceuticals, INC. | $14.30 | 2021 | |
| Novo Nordisk INC | $14.23 | 2019 | |
| Amag Pharmaceuticals, INC. | $14.02 | 2020 | |
| Exeltis, USA INC. | $12.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Perry Justice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.